Skip to main content

Electronic Prescribing and Medicines Administration (EPMA) Data

Data Provision Notice to provide NHS Digital with prescribing and medicines data from up to 64 NHS hospitals using the Cerner and WellSky EPMA systems, to support COVID-19 analysis, planning and research activity.

Overview

The prescribing and medicines data is required by NHS Digital to support vital analysis, linkage and sharing of data including for:

  • COVID-19 surveillance
  • COVID-19 medicines research
  • the monitoring of data prescribed for COVID-19 patients
  • the monitoring of prescribing patterns before, during and after COVID-19.

Scope of the collection

This Notice is served on:

  • the NHS hospitals in England using the Cerner or WellSky EPMA  systems which have agreed to participate in the collection.

Legal basis for provision of data

NHS Digital has been directed by the Secretary of State under section 254 of the Act to establish and operate a system for the collection and analysis of the information specified for this service. 

Collection

Phase 1 of the collection will commence from June 2020, with Phase 2 due to begin in October 2020. Dates will be agreed with each participating trust.

In Phase 1, the collection will take data from 1 January 2020, followed by daily submissions (commencing August 2020) for a period of approximately 2 weeks.

In Phase 2, a collection will be made to cover a longer retrospective period, from 1 January 2019, followed by daily submissions to be continued until further notice.

The period of this collection will not continue past 31 March 2022, which is when its current legal basis – the COVID-19 Public Health Directions 2020 -  expires.

Read the Data Provision Notice

Last edited: 14 August 2020 9:55 am